TCR2 Therapeutics (TCRR) Return on Assets (ROA)

Price: $1.48
Market Cap: $58.11M
Avg Volume: 325.04K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.93322
52W Range: $0.821-3.88
Website: TCR2 Therapeutics

TCR2 Therapeutics Return on Assets (ROA) Summary

TCR2 Therapeutics's ROA indicates the return generated on the company's assets:

  • Annual: -72.91%
  • Quarterly: -26.66%
  • TTM: -72.91%

What is Return on Assets (ROA)?

Return on Assets (ROA) is a financial ratio that shows the percentage of profit a company earns in relation to its overall resources. It is an indicator of how efficiently a company is using its assets to generate earnings.

Related Metrics

Other important metrics to assess TCR2 Therapeutics's profitability include:

  • ROE (Return on Equity) - measures the return generated on shareholders' equity:
    • Annual: -107.78%
    • Quarterly: -39.87%
    • TTM: -71.90%
  • ROIC (Return on Invested Capital) - measures how effectively the company uses its invested capital to generate profits:
    • Annual: -79.01%
    • Quarterly: -38.68%
    • TTM: -79.01%
  • Return on Tangible Assets - measures the return generated on the company's tangible assets:
    • Annual: -72.91%
    • Quarterly: -26.66%
    • TTM: -72.91%
  • Profit Margin - shows the percentage of revenue that has turned into profit:
    • Annual: 0.00%
    • Quarterly: 0.00%
    • TTM: 0.00%

These metrics provide insights into TCR2 Therapeutics's profitability and efficiency in using its capital and assets to generate returns. Comparing these ratios with industry benchmarks can offer a deeper understanding of the company's performance.

Annual ROA

-72.91%

Quarterly ROA

-26.66%

TTM ROA

-72.91%

TCR2 Therapeutics Historical ROA
0.00%0.00%-14.58%-14.58%-29.16%-29.16%-43.75%-43.75%-58.33%-58.33%-72.91%-72.91%ROA20172017201820182019201920202020202120212022202220232023
Historical ROE
89.20%89.20%23.54%23.54%-42.12%-42.12%-107.78%-107.78%ROE20172017201820182019201920202020202120212022202220232023
Historical ROIC
106.79%106.79%44.86%44.86%-17.07%-17.07%-79.01%-79.01%ROIC20172017201820182019201920202020202120212022202220232023
Historical Profit Margin
200.00%200.00%160.00%160.00%120.00%120.00%80.00%80.00%40.00%40.00%0.00%0.00%Profit Margin20172017201820182019201920202020202120212022202220232023
Historical Return on Tangible Assets
0.00%0.00%-14.58%-14.58%-29.16%-29.16%-43.75%-43.75%-58.33%-58.33%-72.91%-72.91%Return on Tangible Assets20172017201820182019201920202020202120212022202220232023

TCR2 Therapeutics Historical Profitability Metrics

The table below shows various profitability metrics for each year, with the latest data available for the last fiscal year 2022.

Year ROA ROE ROIC Profit Margin Return on Tangible Assets
2022 -72.91% -107.78% -79.01% 0.00% -72.91%
2021 -30.86% -35.46% -32.49% 0.00% -30.86%
2020 -27.26% -28.38% -29.11% 0.00% -27.26%
2019 -28.24% -29.67% -32.09% 0.00% -28.24%
2018 -18.74% 28.30% 33.67% 0.00% -18.74%
2017 -59.30% 49.65% 50.49% 0.00% -59.30%
2016 -54.33% 83.43% 83.68% 0.00% -54.33%

Related Metrics

Explore detailed financial metrics and analysis for TCRR.